The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Tardive dyskinesia (TD) is an involuntary movement condition, meaning you can't control your movements. "Tardive" means late, and "dyskinesia" means uncontrolled movements. It's often a side ...

Biliary dyskinesia is a functional disorder that occurs when your gallbladder (a small pear-shaped organ that stores and processes) can't contract and release bile effectively. Bile is important ...

Tardive dyskinesia (TD) is a form of drug-induced (iatrogenic) movement disorder that is one form of tardive syndrome. Other forms of tardive syndrome include tardive stereotypy, tardive chorea, ...

TD, or tardive dyskinesia, is pretty much uncontrollable, jerky movements of the body. Smacking of the lips, licking, or jaw movements. I have Tourette's, and I kind of feel like it's just an ...

Uncontrollable movements from tardive dyskinesia (TD) can put a strain on your daily life, physically and mentally. Developing a stress management routine, employing social strategies, and seeking ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease.

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...